Thomson Reuters Prous Science, a Thomson Reuters business
Translational Research
Clinical Medicine
Prous Science Solutions
October 14, 2008
Predictive Pharmacology Module
Molecule of the Month Molecule of the Month
This month: The orthopoxvirus egress inhibitor tecovirimat, a promising treatment for smallpox
BIOMARKERcenter Webcast
BIOMARKERcenter
BIOMARKERcenter:
A unique biomarker knowledge store to connect experimental research, drug R&D and clinical studies for pivotal insights and decision making
The European Breast Cancer Coalition Breast Health Day – October 15, 2008
EUROPA DONNA – The European Breast Cancer Coalition is holding Breast Health Day to disseminate information concerning breast health and to raise awareness of prevention and early detection of breast cancer among women and girls across Europe.
More
Images & Pathways ISCP Cardio
Images & Pathways
Animation Available:
Hedgehog signaling in fetal and adult brain
ISCP CardioInternational Society Cardiovascular Pharmacotherapy
The ISCP is a society devoted to education and medical research in the field of cardiovascular pharmacotherapy, as well as to the international exchange of information and to the needs of cardiovascular pharmacotherapy with special focus on developing countries.
DailyDrugNews.com
Discover new information presented at recent conferences, including:
(for subscribers only)
Annual Congress of the European Respiratory Society (ERS) (October 4-8, Berlin)
National Cancer Research Institute Cancer Conference (October 5-8, Birmingham)
6th World Stroke Congress (September 24-27, Vienna)
UBS Global Life Sciences Conference (September 22-25, New York)
To obtain subscription information, please click here
What's New What's New

Drugs of the Future
Proceedings of the XXth International Symposium on Medicinal Chemistry (August 31 - September 4, Vienna)

Drug News & Perspectives
Recent studies with small-molecule inhibitors demonstrate Btk's potential as a therapeutic target for some of the most difficult diseases such as rheumatoid arthritis and lymphoma.

Drugs of the Future
An overview of trends in the treatment of schizophrenia emphasizes the need for drugs acting through different mechanisms based on the multidimensional symptomatology of the disorder, and highlights promising developments.

Add RSS Headlines
Copyright 2008 Prous Science S.A.U. or its licensors.
All rights reserved. Legal Information.
Send your comments to Webmaster.